<?xml version="1.0"?>
<feed xmlns="http://www.w3.org/2005/Atom" xml:lang="en">
	<id>https://wikimd.org/index.php?action=history&amp;feed=atom&amp;title=Azaserine</id>
	<title>Azaserine - Revision history</title>
	<link rel="self" type="application/atom+xml" href="https://wikimd.org/index.php?action=history&amp;feed=atom&amp;title=Azaserine"/>
	<link rel="alternate" type="text/html" href="https://wikimd.org/index.php?title=Azaserine&amp;action=history"/>
	<updated>2026-04-26T19:54:16Z</updated>
	<subtitle>Revision history for this page on the wiki</subtitle>
	<generator>MediaWiki 1.44.2</generator>
	<entry>
		<id>https://wikimd.org/index.php?title=Azaserine&amp;diff=5650320&amp;oldid=prev</id>
		<title>Prab: CSV import</title>
		<link rel="alternate" type="text/html" href="https://wikimd.org/index.php?title=Azaserine&amp;diff=5650320&amp;oldid=prev"/>
		<updated>2024-04-23T20:58:44Z</updated>

		<summary type="html">&lt;p&gt;CSV import&lt;/p&gt;
&lt;p&gt;&lt;b&gt;New page&lt;/b&gt;&lt;/p&gt;&lt;div&gt;[[File:Azaserine.svg|Azaserine|thumb]] &amp;#039;&amp;#039;&amp;#039;Azaserine&amp;#039;&amp;#039;&amp;#039; is a [[glutamine]] antagonist, which was discovered to have [[antineoplastic]] properties. It is a natural product, isolated from [[Streptomyces]] bacteria, and has been studied for its potential use in [[cancer]] research. Azaserine functions by inhibiting [[glutamine]]-utilizing enzymes, which are essential for the synthesis of [[nucleotides]] and the proliferation of cancer cells. This mechanism of action places azaserine in the category of [[antimetabolites]], a class of drugs that interfere with the normal metabolism and growth of cancer cells.&lt;br /&gt;
&lt;br /&gt;
==Mechanism of Action==&lt;br /&gt;
Azaserine works by specifically targeting and inhibiting the activity of [[glutamine amidotransferase]] enzymes. These enzymes play a crucial role in the biosynthesis of purines and pyrimidines, which are necessary for [[DNA]] and [[RNA]] synthesis. By inhibiting these enzymes, azaserine effectively blocks the proliferation of rapidly dividing cells, particularly malignant cells. Its action is similar to that of [[DON (6-Diazo-5-oxo-L-norleucine)]], another glutamine antagonist with antineoplastic properties.&lt;br /&gt;
&lt;br /&gt;
==Research and Clinical Use==&lt;br /&gt;
Although azaserine has shown promise in preclinical studies, its use in clinical settings has been limited. The research has primarily focused on its potential as a chemotherapeutic agent, either alone or in combination with other anticancer drugs. However, due to its toxicity and the development of more effective and less toxic anticancer agents, azaserine has not become a standard treatment for cancer.&lt;br /&gt;
&lt;br /&gt;
==Toxicity and Side Effects==&lt;br /&gt;
Like many chemotherapeutic agents, azaserine can cause a range of side effects, including [[toxicity]] to normal cells, particularly those that divide rapidly, such as cells in the [[gastrointestinal tract]], [[bone marrow]], and [[hair follicles]]. This can lead to side effects such as [[nausea]], [[vomiting]], [[hair loss]], and [[myelosuppression]] (a decrease in bone marrow activity, leading to reduced numbers of red and white blood cells and platelets).&lt;br /&gt;
&lt;br /&gt;
==Current Status and Future Directions==&lt;br /&gt;
Research on azaserine as a potential anticancer agent has diminished over the years, with the focus shifting towards more effective and targeted therapies with fewer side effects. However, studying azaserine and other glutamine antagonists continues to provide valuable insights into cancer metabolism and the role of glutamine in cell proliferation. These insights may lead to the development of new therapeutic strategies and drugs targeting cancer metabolism.&lt;br /&gt;
&lt;br /&gt;
[[Category:Antineoplastic agents]]&lt;br /&gt;
[[Category:Glutamine antagonists]]&lt;br /&gt;
{{medicine-stub}}&lt;/div&gt;</summary>
		<author><name>Prab</name></author>
	</entry>
</feed>